Archives: Agenda

• Interacting earlier for supply to give input and gain information sooner so they can assist and be prepared
• Establishing clinical team needs: what, when and where
• Building and maintaining strong relationships between teams

• Classifying clinical materials correctly to avoid delays or unexpected costs
• Collaborating with brokers and logistics partners to ensure compliant, efficient importation
• Determining duty rates and entry rates for different types of clinical trial materials and products
• Applying for duty exemptions: are you eligible?

Support teams are often seen as reactive problem-solvers—but what happens when they’re embedded early in the trial lifecycle? This session explores how technical support can play a proactive role in study success. We’ll discuss how early involvement in processes like the Study Maintenance Plan and Go-Live allows support teams to anticipate challenges, prepare sponsors and sites, and respond more effectively when issues arise. Join us for a practical conversation on how collaboration and foresight can make support a strategic asset in clinical trial delivery.

• Evaluating sourcing, shelf-life and regulatory constraints for high risk items
• Mapping global supply chain dependencies and transit vulnerabilities
• Implementing strategies to mitigate against supply chain risk
• Collaborating cross-functionally to align risk assessment with trial timelines and priorities

• Designing flexible IRT systems to accommodate multiple dose levels and protocol adaptations
• Forecasting clinical supply needs amid uncertainty in dosing, cohorts and timelines
• Collaborating across functions to align IRT, supply and clinical execution
• Applying lessons learned from a real world CNS program with high complexity and unpredictability

MODERATOR: Luiz Barberini, Head of External Manufacturing, Latin America, Bayer